By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The House of Representatives committee that serves as a government watchdog held a hearing yesterday focused on whether an overstretched Food and Drug Administration is slowing down the advance of new medical devices, hurting the growth of industry, and making venture investors skittish about backing medical device start-ups.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.